Today, three quarters or more of all childhood cancer patients will be cured of their disease, a higher percentage than ever before. And the numbers will only get better as we learn more about the biology of childhood cancers and develop new ways of treating them.
Archive for Dana-Farber
One of the oldest healing practices in the world, acupuncture is beginning to have a role in alleviating pain and discomfort associated with cancer and its treatments. Acupuncturists use fine needles to penetrate the skin and stimulate – manually or electrically – specific points on the body.
Quite a few substances used in traditional medicine in China or other countries have received Food and Drug Administration (FDA) approval as cancer drugs… and their numbers are growing. Some examples are:
Arsenic trioxide, made from arsenic sulfide ore, has been used therapeutically for more than 2,400 years. Following promising reports from China, the agent was tested in clinical trials and received FDA approval in 2000 for patients with acute promyelocytic leukemia who have not responded to other therapies or whose disease has recurred.
One of the goals of the Rally for Medical Research, held in conjunction with the American Association for Cancer Research (AACR) 2013 Annual Meeting, earlier this month was to bring awareness to and education about the impact of the cuts in federal funding for medical research.
Dana-Farber’s Kenneth C. Anderson, MD participated in the Rally. He says in this video, that the scientists who exist today are extraordinary, and for the new generation of cancer researchers to build on today’s advances, it is all dependent on funding from the National Institutes of Health and the National Cancer Institute.
If you have your first chemotherapy appointment coming up, you’re likely thinking about a hundred things. In this short video, a Dana-Farber breast cancer patient walks us through the chemotherapy infusion process. If you’re anxious about your first chemo appointment, the video is a good place to start.
If you’re also wondering about the logistics of it all, here are some practical tips gathered from patients who have been there. Read more
April 2011 was an auspicious month for Hilary Hall. The start of spring marked 15 years of her being cancer-free, as well as the anniversary of her bone marrow transplant in April 1996 at age 12 for acute myelogenous leukemia. It also marked the first time Hall would lace up her running shoes for the Boston Marathon.
“When I heard about the marathon in October 2010, I instantly knew that this was how I would celebrate,” she says.
More than 18,000 cancer scientists from around the world are in Washington, D.C., this week for the annual meeting of the American Association for Cancer Research (AACR). The meeting serves as a forum for the presentation and discussion of the latest discoveries in cancer research.
The meeting coincides with the Rally for Medical Research, which was held Monday morning on the steps of the Carnegie Library in the nation’s capital.
Like many New Englanders, Fernando Morales can’t wait for Opening Day and the start of the baseball season. And, even if his favorite Boston Red Sox aren’t doing well, this 18-year-old high school senior from Norwood, Mass., says he’ll never waver in his devotion.
He has good reason for his loyalty. As a patient at Dana-Farber Cancer Institute’s Jimmy Fund Clinic since April 2011, Morales has endured chemotherapy, shots, hair loss, and more for treatment of Ewing sarcoma, a tumor of the bone and soft tissue. He’s had to quit playing soccer and running track, but he’s still getting his baseball fix thanks to the relationship between the Red Sox and the Jimmy Fund of Dana-Farber.
By Jane Roper
When our five-year-old daughter was diagnosed with leukemia (ALL) last summer, our world was turned upside down.
Extended hospital stays, twice weekly clinic visits, the side effects of chemo and the constant possibility of unexpected hospital admissions mean stress and exhaustion for all of us. And looming in the background of it all is the unspoken worry: will our daughter get through this?
In a recent study, Oxford University researchers reported that although radiation therapy is a critical tool for the treatment of women with breast cancer, it can also raise their risk of a heart attack or heart disease later in life. The study was based on a review of medical records of 2,168 women in Sweden and Denmark who received radiation therapy for breast cancer between 1958 and 2001, and who were under age 70 at the time.
News coverage of the study, published in the New England Journal of Medicine, has drawn new attention to the heart risks associated with radiation therapy even as it underscores such therapy’s role in improving survival rates for breast cancer patients.